Tumor-derived vaccines containing CD200 inhibit immune activation: Implications for immunotherapy

Zhengming Xiong, Elisabet Ampudia-Mesias, Rob Shaver, Craig M. Horbinski, Christopher L. Moertel, Michael R. Olin*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Tumor-derived vaccines containing CD200 inhibit immune activation: Implications for immunotherapy'. Together they form a unique fingerprint.

INIS

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science